Lumateperone Tosylate

CAS 1187020-80-9 5 current recordsSmall Molecule

Who holds supplier records for Lumateperone Tosylate? 5 organisations hold a current record for Lumateperone Tosylate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (4) and China (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Lumateperone Tosylate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/lumateperone-tosylate

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    4 of the 5 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Lumateperone Tosylate. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • DASAMI LAB PRIVATE LTD
    Active DMF 38407 · latest filing Jul 2023
    India Company GMP cert on record
  • Dr. Reddy's Laboratories Ltd.
    Active DMF 38206 · latest filing Mar 2023
    India Company GMP cert on record
  • Maithri Laboratories Private Limited
    Active DMF 38730 · latest filing Sept 2023
    India Company GMP cert on record
  • Zhejiang Ausun Pharmaceutical Co., Ltd.
    Active DMF 42658 · latest filing Oct 2025
    China Company GMP cert on record
  • Zydus Lifesciences Limited
    Active DMF 38778 · latest filing Sept 2023
    India Company GMP cert on record
Need Lumateperone Tosylate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Lumateperone Tosylate is an atypical antipsychotic used in the treatment of schizophrenia and bipolar disorder. Its mechanism involves modulation of serotonin and dopamine receptors, providing efficacy in psychiatric conditions.

Chemical identity

IUPAC name
1-(4-fluorophenyl)-4-[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one;4-methylbenzenesulfonic acid
Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCN2[C@H]3CCN(C[C@H]3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F
InChIKey
LHAPOGAFBLSJJQ-GUTACTQSSA-N
Synonyms
Caplyta API, caplyta, iti-007 tosylate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Atypical Antipsychotic

Therapeutic areas

PsychiatryNeurology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Lumateperone Tosylate?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Lumateperone Tosylate: DASAMI LAB PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India), Maithri Laboratories Private Limited (India), Zhejiang Ausun Pharmaceutical Co., Ltd. (China) and Zydus Lifesciences Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Lumateperone Tosylate Drug Master Files are active?

DASAMI LAB PRIVATE LTD (DMF 38407), Dr. Reddy's Laboratories Ltd. (DMF 38206), Maithri Laboratories Private Limited (DMF 38730), Zhejiang Ausun Pharmaceutical Co., Ltd. (DMF 42658) and Zydus Lifesciences Limited (DMF 38778). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Lumateperone Tosylate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Lumateperone Tosylate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.